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  Limited	  research	  suggests	  that	  supplementing	  with	  tart	  cherry	  juice	  reduces	  inflammation	  and	  decreases	  symptoms	  of	  arthritis	  in	  adults.	  The	  majority	  of	  research	  with	  tart	  cherries	  utilizes	  a	  juice	  form	  of	  supplementation,	  which	  is	  high	  in	  sugar	  and	  may	  increase	  inflammation.	  An	  alternative	  is	  powdered	  cherry	  capsules,	  which	  contain	  435	  mg	  of	  freeze	  dried	  Montmorency	  cherry,	  the	  equivalent	  of	  16	  oz.	  of	  tart	  cherry	  juice	  and	  less	  than	  1g	  sugar.	  However,	  it	  is	  not	  known	  how	  the	  powdered	  cherry	  supplement	  affects	  markers	  of	  inflammation	  in	  patients	  with	  arthritis.	  PURPOSE:	  to	  investigate	  the	  effects	  of	  tart	  cherry	  powder	  supplement	  as	  compared	  to	  a	  placebo	  on	  inflammation	  and	  quality	  of	  life	  in	  patients	  diagnosed	  with	  arthritis.	  METHODS:	  10	  participants	  (2	  Male;	  Age:	  51	  ±	  11	  yo,	  Height:	  165	  ±	  8	  cm,	  Weight:	  75	  ±	  19	  kg)	  previously	  diagnosed	  by	  a	  physician	  with	  arthritis	  consumed	  either	  placebo	  or	  freeze	  dried	  tart	  cherry	  capsules	  twice	  daily	  for	  20	  days.	  Biomarkers	  of	  inflammation,	  cholesterol,	  body	  composition	  and	  blood	  pressure	  were	  assessed	  at	  baseline,	  10	  days	  and	  20	  days.	  RESULTS:	  There	  were	  no	  significant	  changes	  in	  blood	  pressure	  or	  body	  composition	  over	  the	  supplementation	  period.	  Similarly,	  uric	  acid	  (TC:	  5.3	  ±	  1.2	  vs.	  5.5	  ±	  1.1	  and	  PL:	  4.9	  ±	  0.6	  vs.	  4.5	  ±	  0.7),	  erythrocyte	  sedimentation	  rate	  (TC:	  16.6	  ±	  9.0	  vs.	  14.8	  ±	  10.08	  and	  PL:	  12.8	  ±	  8.6	  vs.	  10.2	  ±	  11.1)	  and	  quality	  of	  life	  (TC:	  8.0	  ±	  6.0	  vs.	  7.8	  ±	  5.9	  and	  PL:	  5.4	  ±	  5.5	  vs.	  4.0	  ±	  3.7)	  were	  not	  changed	  pre	  to	  20	  days	  post	  supplementation.	  CONCLUSION:	  20	  days	  of	  supplementation	  with	  powdered	  tart	  cherry	  did	  not	  significantly	  affect	  inflammation	  or	  quality	  of	  life	  in	  arthritic	  patients.	  Sample	  size	  was	  small	  as	  this	  was	  a	  pilot	  study,	  therefore	  larger	  scale	  studies	  need	  to	  be	  performed.	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